Chemical Compound
(2R,3S,4S,5R,6R)-3-{[(2R,3R,4R,5R,6R)-5-{[(2R,3R,4R,5S,6S)-6-carboxy-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-3-(sulfoamino)-4-(sulfooxy)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}-5-(sulfooxy)oxane-2-carboxylic acid
CAS Registry Number
104993-28-4
Primary record
(2R,3S,4S,5R,6R)-3-{[(2R,3R,4R,5R,6R)-5-{[(2R,3R,4R,5S,6S)-6-carboxy-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-3-(sulfoamino)-4-(sulfooxy)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}-5-(sulfooxy)oxane-2-carboxylic acid
- 库存
- 885 克
- 纯度
- 98.3 %
- CAS
- 104993-28-4
化合物标识与属性
- CAS
- 104993-28-4
- PubChem CID
- 5282448
- SMILES
- CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O
- Canonical SMILES
- CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O
名称与同义词
- Fondaparinux
- Arixtra
- Heparin pentasaccharide
- fondaparin
- Fondaparinux sodium
- PENTA
- Fondaparin sodium
- Fondaparinuxsodium
- Natural heparin pentasaccharide
- ORG31540 free acid
- ORG-31540 free acid
- J177FOW5JL
- Org 31540
- Org-31540
- RefChem:55228
- UNII-J177FOW5JL
- CHEBI:61033
- FONDAPARINUX [HSDB]
- FONDAPARINUX [VANDF]
- 104993-28-4
- HSDB 7845
- FONDAPARINUX [WHO-DD]
- DTXSID10146903
- AC1NR037
- GTPL6819
- orb1737948
- C31H53N3O49S8
- CHEMBL1201202
- DTXCID9069394
- SCHEMBL17655218
- SR 901107A
- SR-901107A
- CHEBI:139212
- SR 90107A
- SR 90107
- BDBM50511579
- EBC-27567
- IC 85158
- CID5282448
- DB00569
- CID:5282448
- C31-H53-N3-O49-S8
- SR-90107
- SID:134224614
- J862.320A
- TRISULFOAMINO HEPARIN PENTASACCHARIDE
- CS-1000093
- NS00078767
- Y1945
- GlcNS6S-GlcA-GlcNS6S3S-IdoA2S-GlcNS6SOMe
- C064764
- EN300-19769274
- Q27077698
- (2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxyoxan-3-yl]oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid
- methyl 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->4)-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-2-O-sulfo-alpha-L-idopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside
- (2R,3S,4S,5R,6R)-3-{[(2R,3R,4R,5R,6R)-5-{[(2R,3R,4R,5S,6S)-6-carboxy-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-3-(sulfoamino)-4-(sulfooxy)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}-5-(sulfooxy)oxane-2-carboxylic acid
- (2R,3S,4S,5R,6R)-3-(((2R,3R,4R,5R,6R)-5-(((2R,3R,4R,5S,6S)-6-carboxy-5-(((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-((sulfooxy)methyl)oxan-2-yl)oxy)-3,4-dihydroxyoxan-2-yl)oxy)-3-(sulfoamino)-4-(sulfooxy)-6-((sulfooxy)methyl)oxan-2-yl)oxy)-4-hydroxy-6-(((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-((sulfooxy)methyl)oxan-3-yl)oxy)-5-(sulfooxy)oxane-2-carboxylic acid
- (2S,3S,4R,5R,6R)-6-((2R,3R,4R,5R,6R)-6-((2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl)oxy-5-sulfooxyoxan-3-yl)oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl)oxy-3-((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl)oxy-4,5-dihydroxyoxane-2-carboxylic acid
- 350014-67-4
- a-D-Glucopyranoside, methylO-2-deoxy-6-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(14)-O-b-D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(14)-O-2-O-sulfo-a-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate)
- alpha-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopy
- alpha-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate)
- Methyl 2-(sulfoamino)-2-deoxy-4-O-[2-O-sulfo-4-O-[2-(sulfoamino)-2-deoxy-3-O-sulfo-4-O-[4-O-[2-(sulfoamino)-2-deoxy-6-O-sulfo-alpha-D-glucopyranosyl]-beta-D-glucopyranuronosyl]-6-O-sulfo-alpha-D-glucopyranosyl]-alpha-L-idopyranuronosyl]-6-O-sulfo-alpha-D-glucopyranoside
- Methyl 4-O-[4-O-[4-O-[4-O-[2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl]-beta-D-glucopyranuronosyl]-2-deoxy-3-O,6-O-bis(sulfo)-2-(sulfoamino)-alpha-D-glucopyranosyl]-2-O-sulfo-alpha-L-idopyranuronosyl]-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside
- Methyl 4-O-[4-O-[4-O-[4-O-[6-O-sulfo-2-(sulfoamino)-2-deoxy-alpha-D-glucopyranosyl]-beta-D-glucopyranuronosyl]-3-O,6-O-disulfo-2-(sulfoamino)-2-deoxy-alpha-D-glucopyranosyl]-2-O-sulfo-alpha-L-idopyranuronosyl]-6-O-sulfo-2-(sulfoamino)-2-deoxy-alpha-D-glucopyranoside
- NTO